By Editor , 31 October 2026
Lactiga Nasal Antibody Protects Mice Against Flu in Science Advances

North Brunswick, N.J. – October 30, 2026 -- All five antibody-deficient mice treated with Lactiga's LCTG-001 survived influenza infection, compared with two of five in the control group, according to a peer-reviewed preclinical study conducted by McMaster University scientists in collaboration with Lactiga US, Inc.

By Editor , 10 September 2026
AtomVie Opens $160M Radiopharma Plant in Hamilton, Ontario

Hamilton, Ontario – – September 09, 2026 -- AtomVie Global Radiopharma has officially opened a new manufacturing plant at 10 Aeropark Boulevard in Hamilton, Ontario, representing an investment exceeding $160 million and marking the largest contract development and manufacturing organization (CDMO) site in North America dedicated to radiopharmaceutical production.

By Editor , 10 September 2026
AtomVie Opens $160M Radiopharma Plant, 10x Capacity in Ontario

Hamilton, Ontario – September 09, 2026 -- AtomVie Global Radiopharma has opened a new 72,300-square-foot production facility at 10 Aeropark Boulevard in Hamilton, Ontario, backed by more than $160 million in investment and marking the largest single-site radiopharmaceutical CDMO facility in North America.